Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FVUYX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,455
Award facts
- Contract value 100% obligated
- $21,454.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,454.78 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pens in 2 ml units. The contract is a firm fixed price delivery order with an ultimate completion date of June 5, 2025, and was awarded on June 4, 2025, without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026, which serves as the comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Cosentyx is a biologic immunosuppressant used to treat various inflammatory and autoimmune conditions. The competitively awarded contract reflects AmerisourceBergen's established capability to fulfill federal medical supply requirements through the DLA's pharmaceutical prime vendor program, which supports military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FVUYX?
SPE2DB25FVUYX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FVUYX worth?
The government has obligated $21,455 on SPE2DB25FVUYX.
Is contract SPE2DB25FVUYX an order under another contract?
Yes. SPE2DB25FVUYX is a delivery order under SPE2DB25D3504, an indefinite delivery contract.
Was contract SPE2DB25FVUYX competed?
The extent of competition for SPE2DB25FVUYX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award